Long-Term Safety and Effectiveness of Rituximab Biosimilar RTXM83: A Retrospective Extension Study in Brazilian Patients with Diffuse Large B-Cell Lymphoma.
Márcia Torresan DelamainAna Carolina Ferreira CardosoFernando Vieira PericoleSérgio Shusterschitz da Silva AraújoLaura FogliattoMarcia HigashiJuliana PereiraRoberto Luiz da SilvaGustavo WerutskyPatrícia de Paulo Giacon RadtkeMarco Aurélio SalvinoVivienne Carduz CastilhoPublished in: Oncology and therapy (2024)
ClinicalTrials.gov Identifier: NCT04928573. June 16, 2021, "retrospectively registered".